Skip to main content
Fig. 3 | BMC Research Notes

Fig. 3

From: Expression of IL-23 in gilt endometrium and oviduct after insemination with seminal plasma, spermatozoa or semen extender

Fig. 3

Intensity of IL-23 immunolabelling in gilt oviduct and uterus after insemination. IL-23 immunolabelling intensity scores (mean ± sem) in gilt oviduct (isthmus and infundibulum) and uterus at 35–40 h after insemination with spermatozoa in BTS (SPZ), seminal plasma (SP), BTS and catheter-insertion control (Cat; n = 4 per treatment group). BTS Beltsville thawing solution

Back to article page